Not all people with CLL require therapy. Despite all latest advances, the iwCLL continue to recommends watchful observation for individuals with asymptomatic sickness.86 This recommendation is based on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).